Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adenocor 6mg/2ml solution for injection vials
0203020C0BBAAAA
|
Adenocor | Adenosine | Cardiovascular System | No data available |
|
Adenoscan 30mg/10ml solution for infusion vials
0203020C0BCAAAB
|
Adenoscan | Adenosine | Cardiovascular System | No data available |
|
Adenosine 30mg/10ml solution for infusion vials
0203020C0AAABAB
|
Adenosine | Adenosine | Cardiovascular System | No data available |
|
Adenosine 6mg/2ml solution for injection vials
0203020C0AAAAAA
|
Adenosine | Adenosine | Cardiovascular System | No data available |
|
Adrenaline (base) 100microg/1ml (1 in 10,000) dilute inj pfs
0207030A0AAALAL
|
Adrenaline (Parenteral) | Adrenaline | Cardiovascular System | No data available |
|
Adrenaline (base) 1mg/10ml (1 in 10,000) dilute inj Minijet
0207030A0BBABAB
|
Minjet adrenaline (Sympathomimetic) | Adrenaline | Cardiovascular System | No data available |
|
Adrenaline (base) 300microg/3ml (1 in 10,000) dilute inj pfs
0207030A0AAACAC
|
Adrenaline (Parenteral) | Adrenaline | Cardiovascular System | No data available |
|
Adrenaline (base) 300microg/3ml dilute inj Minijet pfs
0207030A0BBAAAC
|
Minjet adrenaline (Sympathomimetic) | Adrenaline | Cardiovascular System | No data available |
|
Advate 1,000unit inj vials
0211000I0BKACAH
|
Advate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Advate 1,500unit inf vials
0211000I0BKADAL
|
Advate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Advate 2,000unit inj vials
0211000I0BKAEAI
|
Advate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Advate 250unit pdr and 2ml solvent for soln for inj vials
0211000I0BKAGAF
|
Advate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Advate 250unit pdr and 5ml solvent for soln for inj vials
0211000I0BKAHAF
|
Advate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Advate 3,000unit inf vials
0211000I0BKAFAP
|
Advate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Advate 500unit pdr and 2ml solvent for soln for inj vials
0211000I0BKAIAG
|
Advate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Advate 500unit pdr and 5ml solvent for soln for inj vials
0211000I0BKAJAG
|
Advate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Alere INRatio testing strips
0208020W0BCAAA0
|
Alere (Reagent) | INR blood testing reagents | Cardiovascular System | No data available |
|
Alkapamid XL 1.5mg tablets (Rivopharm)
0202010P0BPAAAD
|
Alkapamid XL (Rivopharm (UK) Ltd) | Indapamide | Cardiovascular System | No data available |
|
Alphanate 1,000unit inj vials
0211000I0BEABBD
|
Alphanate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Alphanate 1,500unit inj vials
0211000I0BEACAN
|
Alphanate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Alphanate 2,000unit inj vials
0211000I0BEADBE
|
Alphanate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Alphanate 500unit inj vials
0211000I0BEAAAC
|
Alphanate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
AlphaNine 1,000unit inj vials
0211000J0BBABAF
|
AlphaNine | Dried factor IX fraction | Cardiovascular System | No data available |
|
AlphaNine 500unit inj vials
0211000J0BBAAAE
|
AlphaNine | Dried factor IX fraction | Cardiovascular System | No data available |
|
Alphaparin 3,000units/0.3ml inj pre-filled syringes
0208010B0BBAAAA
|
Alphaparin | Certoparin sodium sodium | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.